Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NBI-56418 reduces pain scores in endometriosis patients

Sep. 14, 2006

Hemopure MAA accepted for review in U.K.

Sep. 14, 2006

Codevelopment and comarketing agreements signed for ibandronic acid in Japan

Sep. 14, 2006

Positive preclinical findings for Phenylase

Sep. 14, 2006

Interleukin Genetics studies link between IL-1 gene variations and osteoporosis

Sep. 14, 2006

Merck begins phase I for estrogen receptor compound from Karo Bio collaboration

Sep. 13, 2006

Supprelin-LA NDA accepted for review

Sep. 13, 2006

Symlin improves diabetes control in study

Sep. 12, 2006

Teverelix LA shows potential for endometriosis

Sep. 12, 2006

Takeda discontinues development of TAK-654 for diabetes

Sep. 8, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...